[Yearly Report of the Austrian Committee for Cataract Surgery and Intraocular Implants for 2021].

Spektrum Augenheilkd

Akademisches Lehrkrankenhaus der Barmherzigen Brüder Wien, Johannes von Gott Platz 1, 1020 Wien, Österreich.

Published: September 2022

Background: Every year the Austrian Committee for Cataract Surgery and Intraocular Implants, conducts a national survey of all eye surgery departments in Austria.

Material And Methods: The questionnaires were sent to departments of ophthalmology in Austria and were anonymously returned either in print or via an online form. Before analyzing results, it is important to consider that participation was voluntary and compared to the data of previous years.

Results: The responses of 19 departments of ophthalmology with a total of 182 surgeons are presented in this publication and compared with data from previous years.The participation rate was 79.1% and a total of 66 355 cataract surgeries were reported. There was a slight increase of day clinic surgeries compared to the previous year; however, the number of surgeries is still lower than before the start of the SARS-CoV‑2 pandemic.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510261PMC
http://dx.doi.org/10.1007/s00717-022-00531-yDOI Listing

Publication Analysis

Top Keywords

austrian committee
8
committee cataract
8
cataract surgery
8
surgery intraocular
8
intraocular implants
8
departments ophthalmology
8
compared data
8
data previous
8
[yearly report
4
report austrian
4

Similar Publications

Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]).

Breast Cancer Res

January 2025

Austrian Breast & Colorectal Cancer Study Group (ABCSG), Vienna, Austria.

Background: The PALLAS trial investigated the addition of palbociclib to standard adjuvant endocrine therapy to reduce breast cancer recurrence. This pre-specified analysis was conducted to determine whether adjuvant palbociclib benefited patients diagnosed with lower risk stage IIA disease compared to those with higher stage disease.

Methods: PALLAS was an international, multicenter, randomized, open-label, phase III trial, representing a public-private partnership between Pfizer, the Austrian Breast Cancer Study Group, and the U.

View Article and Find Full Text PDF

Introduction: Microcirculatory alterations are predictive of poor outcomes in patients with shock and after cardiac arrest in animal models. However, microcirculatory alterations during human cardiac arrest have not yet been studied.

Methods: We prospectively included adult patients receiving resuscitation after witnessed out-of-hospital cardiac arrest.

View Article and Find Full Text PDF

Patients with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) primary breast cancer (BC) have low pathological complete response (pCR) rates with neoadjuvant chemotherapy. A subset of ER+/HER2- BC contains dense lymphocytic infiltration. We hypothesized that addition of an anti-programmed death 1 agent may increase pCR rates in this BC subtype.

View Article and Find Full Text PDF

Background: Roux-en-Y gastric bypass may present long-term complications that require revisional surgery or even reversal to normal anatomy. Data on the indications, surgical technique, and outcomes of RYGB reversal remain scarce.

Methods: We identified 48 cases of RYGB reversals with complete 90-day follow-up within a multi-centric international retrospective database of elective secondary bariatric surgery.

View Article and Find Full Text PDF

Renin-angiotensin-aldosterone system activation in plasma as marker for prognosis in critically ill patients with COVID-19: a prospective exploratory study.

Ann Intensive Care

January 2025

Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of General Anaesthesia and Intensive Care Medicine, Medical University of Vienna, Vienna, Austria.

Background: Acute respiratory distress syndrome (ARDS) associated with coronavirus infectious disease (COVID)-19 has been a challenge in intensive care medicine for the past three years. Dysregulation of the renin-angiotensin system (RAS) is linked to COVID-19, but also to non-COVID-19 ARDS. It is still unclear whether changes in the RAS are associated with prognosis of severe COVID-19.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!